Enasidenib Is a Safe and Effective Intervention in IDH2-Mutated AML and MDS - Oncology Nurse Advisor Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated, relapsed or refractory AML.

Adding enasidenib to venetoclax appears to be safe and effective in IDH2-mutated, R/R acute #myeloidLeukemia. Published in @thelancethaem.bsky.social and @hematologyadvisor.bsky.social.

https://bit.ly/49zsjy9

#AML #leusm

Promising New Therapy for Acute Myeloid Leukemia

Einstein Research: Promising New Therapy for Acute Myeloid Leukemia

Read more at bit.ly/441ro8k.

#MedSky #leukemia #myeloidleukemia

#Leukemia, #CML, #BloodCancer, #CancerAwareness, #LeukemiaAwareness, #ChronicMyeloidLeukemia, #Hematology, #Oncology, #BloodDisorders, #CancerResearch, #LeukemiaSupport, #CancerTreatment, #MyeloidLeukemia, #LeukemiaPatients, #BloodCancerAwareness, #CancerFight, #LeukemiaJourney, #CancerSurvivor,

Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.

Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure! #TCSC #cml #myeloid #leukemia #leukaemia #myeloidleukemia #bloodcancer

www.mskcc.org/news/newly-a...